G. Andre Turenne - President and CEO @ Matchpoint Therapeutics

Overview

CB Rank (Investor)

Andre Turenne is the President and CEO at Matchpoint Therapeutics.

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Matchpoint Therapeutics	Access Biotechnology	—	Series A - Matchpoint Therapeutics	obfuscated obfuscation

Number of Current Jobs

Number of Past Jobs

is the

President and CEO

. Additionally,

has had

past job as the

Head of Strategy & Business Development

Organization Name	Title At Company	Start Date	End Date
Sanofi Ventures	Head of Strategy & Business Development	Dec 2012	Dec 2014

Hub Name	CB Rank (Hub)
East Coast Pharmaceutical Companies	7,380
Greater Boston Area Biotechnology Companies	26,552
Cambridge Companies	22,843
Medical Companies with Early Stage Venture Funding	28,822
Harvard Medical School Alumni Founded Companies	66,258
New England Biotechnology Companies	17,498
Alexandria Venture Investments Portfolio Companies	83,257
Biotechnology Early Stage Companies With More Than 10 Employees	24,954
Cambridge Early Stage Companies	89,256
Northeastern US Biotechnology Companies with Early Stage Venture Funding	65,787